For decades, the dominant logic in manufacturing was simple: move production overseas, cut labor costs, and pass savings down the chain. That logic has been tested severely in recent years. Global supply chain disruptions, geopolitical instability, rising overseas wages, and a renewed national conversation about economic resilience have prompted many companies to reconsider. The question is no longer just "where is it cheapest?" but "where does it make the most sense?"
Key Points:
Offshore contract manufacturing does offer real advantages. Labor costs in countries like China, Vietnam, and Mexico have historically been lower, and large factories there can move quickly on high-volume, low-complexity orders. For commodity goods with simple tolerances and minimal regulatory requirements, overseas production can be cost-effective.
These sound overwhelmingly positive, but over time, more problems tend to emerge.
Consider the situation that started on February 28th, when Iran began blocking off the Strait of Hormuz to foreign shipping. Within days of the conflict erupting, tanker traffic through the strait collapsed, restricting shipments by more than 90%. The restrictions on shipping in the strait led to disruptions raising energy and agricultural input costs worldwide. Companies with deep offshore dependencies suddenly found themselves staring at empty pipelines, uncertain timelines, and no viable contingency. According to AAMI, helium and aluminum (both critical for manufacturing many devices) were both impacted due to the strait’s closure and the damage to aluminum plants in the Middle East.
All this to say, these risks being named are not abstract. It is the supply chain risk that procurement teams and CFOs have been warned about for years, and it is happening right now.
Quality control is harder to enforce across 8,000 miles under normal conditions. Shipping delays can stretch lead times from weeks to months even in stable times. Intellectual property protections abroad are often weaker, particularly for proprietary designs and tooling. When disruption strikes (whether from a conflict, a pandemic, a port backlog, or a geopolitical flashpoint), companies with concentrated offshore exposure find themselves with very little room to maneuver. The "savings" erode fast when you factor in scrap rates, rework, logistics costs, and the inventory buffers you carry just to stay ahead of instability.
For industries like medical devices, orthopedics, and defense, these risks carry consequences that go well beyond inconvenience. Regulatory compliance, traceability, and documentation requirements are demanding. A supplier that cuts corners or lacks the certifications to operate in regulated environments is not a savings. It is a liability.
American contract manufacturers offer something offshore facilities often cannot: proximity, communication, and a shared regulatory environment.
There’s also a coordination benefit that’s easy to overlook. When production is spread across multiple vendors, each step introduces another potential delay or point of misalignment. Tooling in one place, molding in another, and assembly somewhere else can slow things down and make issues harder to trace.
Keeping more of the process in one place tends to simplify that. Fewer handoffs mean clearer communication, more accountability, and fewer opportunities for things to slip through the cracks. It doesn’t eliminate challenges, but it makes them easier to manage and resolve.
None of this makes U.S.-based manufacturing the right fit for every situation. But for companies that prioritize responsiveness, visibility, and tighter control over quality, it offers advantages that go beyond cost alone.
Micron Solutions, a leading contract manufacturer in Massachusetts, has operated on exactly this model since 1972. Based in Fitchburg, MA, in a 120,000-square-foot facility, Micron serves medical device OEMs, defense clients, and life sciences companies across the country and around the world. Our capabilities include precision machining, thermoplastic injection molding, mold making, and the production of silver/silver chloride sensors used in disposable electrodes for ECG, EEG, and EMG applications.
Congresswoman Lori Trahan has been a consistent advocate for working families and economic revitalization in North Central Massachusetts, and her recent visit to Micron Solutions highlighted what companies like us represent: stable, skilled jobs, local tax base, and supply chain resilience for industries that matter to national security and public health.
When a medical device company moves production back to the U.S., it creates machinist jobs, engineering roles, quality technician positions. Those workers pay local taxes, buy homes, and send their kids to local schools. The economic multiplier effect of manufacturing employment is among the highest of any sector. According to the Rhode Island Manufacturers Association, every $1 spent in manufacturing adds another $2.74 to the economy.
Offshore manufacturing will remain part of the global supply chain. For certain products at certain volumes, it makes sense. But for companies operating in regulated industries, companies that need responsiveness, traceability, and a partner who will problem-solve alongside them, U.S.-based manufacturing offers advantages that are hard to put a price on.
Micron Solutions, a trusted precision contract manufacturer serving medical, defense, and life sciences clients, is built for exactly those programs. If you are evaluating manufacturing partners and want a team that has been doing this for over 50 years, from prototype to full-scale production, Fitchburg, Massachusetts is worth a conversation. Contact Micron Solutions today to get started.